GENFLOW BIOSCIENCES PLC Logo

GENFLOW BIOSCIENCES PLC

GENF | IL

Overview

Corporate Details

ISIN(s):
GB00BP2C3V08
LEI:
213800HVOFXRXVEGDN62
Country:
United Kingdom
Address:
6 HEDDON STREET, W1B 4BT LONDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genflow Biosciences PLC, founded in 2020, is a biotechnology company developing gene therapies to target the aging process in both humans and dogs. The company focuses on longevity science, aiming to extend healthspan and delay the onset of age-related diseases. Its lead compound, GF-1002, is a therapy based on delivering a centenarian variant of the SIRT6 gene, which has demonstrated promising preclinical results. Genflow's research and development pipeline also includes programs targeting specific age-related conditions such as sarcopenia (muscle loss).

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for GENFLOW BIOSCIENCES PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-27 16:07
Major Shareholding Notification
Holding(s) in Company
English 21.7 KB
2025-08-18 08:00
Regulatory News Service
Company Update on Dog Trials
English 19.7 KB
2025-07-24 08:00
Earnings Release
Clinical Readiness Acceleration
English 17.7 KB
2025-07-17 08:00
Capital/Financing Update
Genflow Confirms Progression of Grant
English 18.0 KB
2025-06-12 11:16
Post-Annual General Meeting Information
Result of AGM
English 30.5 KB
2025-05-28 08:00
Regulatory News Service
Genflow Signs Master Services Agreement
English 13.4 KB
2025-05-15 08:00
Regulatory News Service
Key SIRT6 Patent Application
English 12.3 KB
2025-05-12 11:50
Major Shareholding Notification
Holding(s) in Company
English 68.7 KB
2025-05-07 19:07
Annual Report (ESEF)
Annual financial statements 2024
English 493.4 KB
2025-05-07 19:07
Annual Report
Annual financial statements 2024
English 1.5 MB
2025-03-28 08:10
Major Shareholding Notification
Holding in Company
English 23.0 KB
2025-03-28 08:00
Director's Dealing
Director Dealings
English 25.2 KB
2025-03-26 08:00
Share Issue/Capital Change
Institutional Investment
English 19.6 KB
2025-02-20 08:00
Regulatory News Service
Advancements in SIRT6 Variant Patent Application
English 19.4 KB
2025-01-13 08:30
Major Shareholding Notification
Holding(s) in Company
English 22.3 KB

Automate Your Workflow. Get a real-time feed of all GENFLOW BIOSCIENCES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GENFLOW BIOSCIENCES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN